CGON

CG Oncology, Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1991792Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

3 managers · Q2 2026 13F

13F bookWeight

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

1.3%

+2.6%

$69.1M

$5.25B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.04%

(2.4%)

$27.7M

$71.32B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.03%

+29.8%

$6.3M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.